鸢尾素在2型糖尿病及慢性心力衰竭中的作用机制

doi:10.16352/j.issn.1001-6325.2026.07.1014

摘要/Abstract

摘要： 2型糖尿病(T2DM)和慢性心力衰竭之间存在着密切的病理生理联系。鸢尾素(irisin)作为一种由运动诱导的肌肉因子,在人体内分布广泛,存在着多重生物学功能。研究表明,鸢尾素通过改善胰岛素抵抗、调节糖脂代谢、保护β细胞功能等途径改善T2DM的血糖阈值,并增强心脏干细胞增殖及新生血管生成、改善心脏病理性重构、减少细胞凋亡等机制改善心功能。

关键词: 鸢尾素, 2型糖尿病, 慢性心力衰竭

Abstract: Type 2 diabetes mellitus(T2DM) is closely related to chronic heart failure in the view point of patho-physiological mechanism. Research has shown that irisin as a muscle factor induced by exercise, is widely distributed in human body, which may improve blood glucose threshold of T2DM through a mechanism of reducing insulin resistance, regulating glucose and lipid metabolism, protecting beta cell function, and enhancing cardiac stem cell proliferation and angiogenesis, improving cardiac pathological remodeling, reducing cell apoptosis and so to protect and improve cardiac function.

Key words: irisin, type 2 diabetes mellitus, chronic heart failure

中图分类号:

杨雪, 程晓亮. 鸢尾素在2型糖尿病及慢性心力衰竭中的作用机制[J]. 基础医学与临床, 2026, 46(7): 1014-1018.

YANG Xue, CHENG Xiaoliang. Mechanism of irisin effect in type 2 diabetes mellitus and chronic heart failure[J]. Basic & Clinical Medicine, 2026, 46(7): 1014-1018.

参考文献 23

[1]	Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis[J]. Nature, 2012,481: 463-8. doi: 10.1038/nature10777.
[2]	Chen J, Li K, Shao J, et al. Irisin suppresses nicotine-mediated atherosclerosis by attenuating endothelial cell migration, proliferation, cell cycle arrest, and cell senescence[J]. Front Cardiovasc Med,2022,9:851603. doi: 10.3389/fcvm.2022.851603.
[3]	Lin J, Zhang X, Sun Y, et al. Exercise ameliorates muscular excessive mitochondrial fission, insulin resistance and inflammation in diabetic rats via irisin/AMPK activation[J]. Sci Rep, 2024,14: 10658. doi: 10.1038/s41598-024-61415-6.
[4]	Wang J, Zhao YT, Zhang LX, et al. Irisin deficiency exacerbates diet-induced insulin resistance and cardiac dysfunction in type Ⅱ diabetes in mice[J]. Am J Physiol-Cell Ph, 2023,325: C1085-C1096. doi: 10.1152/ajpcell.00232.2023.
[5]	Lee HJ, Lee JO, Kim N, et al. Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK[J]. Mol Endocrinol, 2015,29: 873-881. doi: 10.1210/me.2014-1353.
[6]	Liu TY, Shi CX, Gao R, et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes[J]. Clin Sci, 2015,129: 839-50. doi: 10.1042/CS20150009.
[7]	Ma EB, Sahar NE, Jeong,M, et al. Irisin exerts inhibitory effect on adipogenesis through regulation of Wnt signaling[J]. Front Physiol, 2019,10:1085. doi: 10.3389/fphys.2019.01085.
[8]	Li T, Yang J, Tan A, et al. Irisin suppresses pancreatic β cell pyroptosis in T2DM by inhibiting the NLRP3-GSDMD pathway and activating the Nrf2-TrX/TXNIP signaling axis[J]. Diabetol Metab Syndr, 2023,15: 239. doi: 10.1186/s13098-023-01216-5.
[9]	Yildiz Kopuz TN, Dagdeviren M, Fisunoglu M. Serum irisin levels in newly diagnosed type-Ⅱ diabetic patients: no association with the overall diet quality but strong association with fruit intake[J]. Clin Nutr ESPEN, 2022,49 357-364. doi: 10.1016/j.clnesp.2022.03.022
[10]	Miyazaki S, Hayashino S, Matsumoto I, et al. Mid-arm muscle circumference as an indicator of exercise tolerance in chronic heart failure[J]. Geriatr Gerontol Int, 2021,21: 411-415. doi: 10.1111/ggi.14154.
[11]	Seo DY, Bae JH, Kim TN, et al. Exercise-induced circulating irisin level is correlated with improved cardiac function in rats[J]. Int J Environ Res Public Health,2020,17: doi: 10.3390/ijerph17113863.
[12]	Wang Z, Li L, Yang M, et al. From skeletal muscle to myocardium: molecular mechanisms of exercise-induced irisin regulation of cardiac fibrosis[J]. Int J Mol Sci, 2025,26: doi: 10.3390/ijms26083550.
[13]	Hu SY, Zhou Y, Zhong SJ, et al. Shenmai injection improves hypertensive heart failure by inhibiting myocardial fibrosis via TGF-β 1/Smad pathway regulation[J]. Chin J Integr Med,2023 Feb;29:119-126. doi: 10.1007/s11655-022-2899-y.
[14]	Buechler MB, Fu, et al. Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer[J]. Immunity,2021,54: 903-915. doi: 10.1016/j.immuni.2021.04.021.
[15]	Hu S, Yang M, Huang S, et al. Different roles of resident and non-resident macrophages in cardiac fibrosis[J]. Front Cardiovasc Med, 2022,9:818188. doi: 10.3389/fcvm.2022.818188.
[16]	Rahman MM, Hwang SM, Go EJ, et al. Irisin alleviates CFA-induced inflammatory pain by modulating macrophage polarization and spinal glial cell activation[J]. Biomed Pharmacother, 2024,178:117157. doi: 10.1016/j.biopha.2024.117157.
[17]	Zhang X, Hu C, Kong CY, et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT[J]. Cell Death Differ,2019,27: 540-555. doi: 10.1038/s41418-019-0372-z.
[18]	Li Q, Zhang M, Zhao Y, et al. Irisin protects against LPS-stressed cardiac damage through inhibiting inflammation, apoptosis, and pyroptosis[J]. Shock,2021,56: 1009-1018. doi: 10.1097/SHK.0000000000001775.
[19]	Pan JA, Zhang H, Lin H, et al. Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulat-ing ROS accumulation and autophagy disorder in endothelial cells[J]. Redox Biol, 2021,46:102120. doi: 10.1016/j.redox.2021.102120.
[20]	Zhao YT, Wang J, Yano N, et al. Irisin promotes cardiac progenitor cell-induced myocardial repair and functional improvement in infarcted heart[J]. J Cell Physiol, 2018,234: 1671-1681. doi: 10.1002/jcp.27037
[21]	Sobieszek G, Powrózek T, Mazurek M, et al. Electrical and hormonal biomarkers in cachectic elderly women with chronic heart failure[J]. J Clin Med, 2020,9: doi: 10.3390/jcm9041021.
[22]	Berezin AA, Lichtenauer M, Boxhammer E, et al. Discriminative value of serum irisin in prediction of heart failure with different phenotypes among patients with type 2 diabetes mellitus[J]. Cells, 2022,11: doi: 10.3390/cells11182794.
[23]	Berezin AA, Lichtenauer M, Boxhammer E, et al. Serum levels of irisin predict cumulative clinical outcomes in heart failure patients with type 2 diabetes mellitus[J]. Front Physiol,2022,13:922775. doi: 10.3389/fphys.2022.922775.